Largest study of herpes simplex virus type 2 to date finds asymptomatic carriers can transmit virus to partners
April 25, 2011
Persons who have tested positive for herpes simplex virus type 2 but do not have symptoms or genital lesions still experience virus shedding during subclinical episodes, suggesting a high risk of transmission from persons with unrecognized HSV-2 infection, according to a study in the April 13 issue of the Journal of the American Medical Association.
Research led by Larry Corey of the Vaccine and Infectious Disease Institute explains why even treated genital herpes sores boost the risk of HIV infection
Aug. 3, 2009
Scientists, led by Drs. Lawrence Corey and Jia Zhu, of the Fred Hutchinson Cancer Research Center, and Dr. Anna Wald, of the University of Washington, uncovered details of an immune-cell environment conducive to HIV infection that persists at the location of HSV-2 genital skin lesions long after they have been treated with oral doses of the drug acyclovir and have healed and the skin appears normal. The findings appear in the Aug. 2 advance online edition of Nature Medicine.
Citing a new study from Uganda, Dr. Judith Wasserheit's New England Journal of Medicine editorial concludes 'circumcision offers an important prevention opportunity and should be widely available'
March 30, 2009
According to an editorial by Dr. Judith Wasserheit, of the Fred Hutchinson Cancer Research center Clinical Research Division and the Vaccine and Infectious Disease Institute, co-authored by Dr. Matthew Golden of the University of Washington Center for AIDS and STD and the Seattle-King County Public Health Department’s STD Control Program, circumcision of adult and newborn males is an important tool for preventing HIV and other sexually-transmitted diseases and should be made widely available in areas of high disease prevalence around the world, according to a recent editorial in last week’s New England Journal of Medicine.